smartwatch controlled supplementation for high risk medical workers


Assess the efficacy of therapeutic supplementation when administered as directed in accordance to physiological smartwatch readings (temperature, heart-rate, blood pressure, etc).


Early Intervention is the key to maintaining health when using therapeutic levels of certain supplements to ward off disease and sickness. By using a smartwatch that monitors key health indicators such as temperature, heart-rate, and possibly other factors, it can be used to instruct the wearer when to take prophylactic supplementation of the needed nutrients to keep the wearer at optimal performance and not get sick.


Usually most people are not immediately aware when they are coming down with an illness of sorts until after it is too late to “nip it in the bud”. For this reason it is reasonable to conclude that many if not most or all studies that have demonstrated a lack of prophylactic efficacy to ward of impending illnesses are based on faulty data of two kinds: (1) the patient is not taking enough of a therapeutic dose of the necessary prophylactic supplement, due largely to the fact that over a long period it is far more than is necessary to maintain health when the patient is not at high risk to develop an illness, and/or (2) if an adequate dose to ward off the illness is taken, it is often taken too late, ie. after the infection (for example) has already spread throughout the host’s body, in which case it wasn’t even taken as a prophylactic. This study circumvents those possibilities by allowing the wearer of the watch to not take a prophylactic at the therapeutic levels until needed, and then when needed, they are able to take a sufficiently high dose to ward of the illness before the illness has put the patient in a health compromised condition.


Alert wearer to take prophylactic when the temperature and heart-rate and other physiological data indicate that the wearer might be coming down with symptoms.


Determine the efficacy strategically timed prophylactic dosing.

  • TBD
  • Experimental
  • Preliminary investigation
  • TBD
  • yes
  • yes
  • double-blind
  • High stress, high contagion risk workplace settings, where the workload can be high.

  • 100000
  • n/a
  • tbd

  • none
  • Patients on any kind of pharmaceuticals or supplement.

  • 300
  • 400
  • 500
  • 999
  • 999
  • 999